Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : TAK crawled time : 08:00 save search
Polpharma Biologics' investigational biosimilar shows PK/PD comparability to inflammatory bowel disease blockbuster Entyvio®
Published: 2024-02-21 (Crawled : 08:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.88%
H: 0.34%
C: 0.34%
entyvio disease biosimilar
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K
|
Health Technology
|
| O: -2.79%
H: 0.62%
C: 0.62%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 2.06%
H: 0.82%
C: 0.82%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: -2.2%
H: 0.0%
C: -0.27%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.64%
H: 0.5%
C: 0.5%
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.42%
H: 0.67%
C: 0.25%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.2%
H: 0.55%
C: 0.1%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.08%
H: 1.45%
C: 1.17%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.05%
H: 0.3%
C: -0.76%
reach market
Takeda Announces FY2023 H1 Results; Updates Full-Year Forecasts While Remaining on Track Towards Management Guidance
Published: 2023-10-26 (Crawled : 08:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -4.69%
H: 0.69%
C: -3.18%
fy2023 management
Mild Cognitive Impairment (MCI) Treatment Market to Experience Substantial CAGR Growth of 8.7% by 2029, Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis
Published: 2023-02-16 (Crawled : 08:00) - prnewswire.com
UCBJY | $64.07 -4.38% 72K
|
Manufacturing
|
| O: -1.68%
H: 0.0%
C: -0.76%
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: -1.1%
H: 0.21%
C: -0.6%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.89%
H: 0.71%
C: 0.26%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -1.48%
H: 0.55%
C: 0.08%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.19%
H: 0.36%
C: -0.52%
treatment growth market
Takeda Delivers Strong FY2022 H1 Results and Raises Full-Year Forecast
Published: 2022-10-27 (Crawled : 08:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 1.0%
H: 2.44%
C: -0.46%
fy2022 results
Takeda Delivers Strong First Quarter FY2022 Results; On Track Towards Full-Year Management Guidance
Published: 2022-07-28 (Crawled : 08:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.07%
H: 1.46%
C: 0.89%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
fy2022 management
Novel T-Cell Immunotherapies Market - Future Pipeline/Clinical Trial Analysis and Revenue Forecast Snapshot - Exclusive Report by InsightAce Analytic
Published: 2022-06-23 (Crawled : 08:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 1.56%
H: 0.73%
C: 0.44%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 4.14%
H: 0.0%
C: 0.0%
report t-cell trial market
Ipsen: European Commission Approves Cabometyx® as a Second-Line Treatment for People Living With Radioactive Iodine-Refractory Differentiated Thyroid Cancer
Published: 2022-05-03 (Crawled : 08:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
cabometyx treatment cancer
CBC Group-backed Hasten Biopharma successfully completes acquisition of five cardiovascular and metabolism drugs from Takeda
Published: 2022-03-31 (Crawled : 08:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.14%
H: 0.49%
C: -0.62%
biopharma acquisition cardiovascular drug
Ipsen: Cabometyx® in Combination With Opdivo® Demonstrated Continued Survival and Quality of Life Benefits With Over Two Years of Follow-Up in the Phase III CheckMate -9ER Trial
Published: 2022-02-15 (Crawled : 08:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.4%
H: 0.53%
C: 0.46%
EXEL | $22.47 -1.75% -1.78% 2.6M
|
Health Technology
|
| O: 0.86%
H: 3.36%
C: 2.29%
cabometyx opdivo trial
Takeda Delivers Strong Third Quarter FY2021 Results and Raises Full-Year Forecast Reflecting Strong Momentum
Published: 2022-02-03 (Crawled : 08:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.55%
H: 1.5%
C: -1.3%
fy2021 liver results
Takeda Delivers Resilient FY2020 Results With Strong Margins & Robust Cashflow; Underlying Revenue Growth Expected to Accelerate in FY2021
Published: 2021-05-11 (Crawled : 08:00) - biospace.com/
BX | $120.32 -2.33% -0.49% 5.7M
|
Finance
|
| O: -2.01%
H: 1.74%
C: 1.15%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.71%
H: 0.45%
C: -0.77%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.22%
H: 0.13%
C: -1.04%
results ev growth liver
Regenerative Medicine Market Revenue Worth $39,012 Million by 2030: P&S Intelligence
Published: 2021-03-16 (Crawled : 08:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.32%
H: 0.53%
C: -0.11%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.14%
H: 0.82%
C: 0.7%
VCEL | $43.86 -5.19% -5.47% 430K
|
Health Technology
|
| O: 0.93%
H: 0.06%
C: -5.0%
IART | News | $31.63 -0.97% -0.98% 510K
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -1.82%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.91%
H: 1.64%
C: 0.93%
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.